Asahi Life Asset Management Co., Ltd. Biogen Inc. Transaction History

Asahi Life Asset Management Co., Ltd.

  • $165 Million
  • Q3 2024

A detailed history of Asahi Life Asset Management Co., Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Asahi Life Asset Management Co., Ltd. holds 1,800 shares of BIIB stock, worth $268,236. This represents 0.21% of its overall portfolio holdings.

Number of Shares
1,800
Holding current value
$268,236
% of portfolio
0.21%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
BUY
$189.07 - $236.8 $340,326 - $426,240
1,800 New
1,800 $348,000
Q1 2024

May 03, 2024
BUY
$212.02 - $267.71 $351,953 - $444,398
1,660 New
1,660 $357,000
Q1 2023

May 01, 2023
SELL
$256.56 - $292.34 $3,848 - $4,385
-15 Reduced 1.13%
1,310 $364,000
Q4 2022

Feb 10, 2023
SELL
$252.44 - $306.72 $130,006 - $157,960
-515 Reduced 27.99%
1,325 $366,000
Q3 2022

Nov 07, 2022
BUY
$194.69 - $268.46 $1,946 - $2,684
10 Added 0.55%
1,840 $491,000
Q2 2022

Aug 02, 2022
BUY
$187.54 - $223.02 $343,198 - $408,126
1,830 New
1,830 $373,000
Q1 2021

May 07, 2021
SELL
$242.95 - $284.63 $519,913 - $609,108
-2,140 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$236.26 - $355.63 $70,878 - $106,689
300 Added 16.3%
2,140 $524,000
Q3 2020

Nov 02, 2020
BUY
$264.77 - $305.71 $209,168 - $241,510
790 Added 75.24%
1,840 $522,000
Q2 2020

Aug 05, 2020
BUY
$258.66 - $342.55 $271,593 - $359,677
1,050 New
1,050 $281,000
Q1 2020

May 15, 2020
SELL
$268.85 - $341.04 $494,684 - $627,513
-1,840 Closed
0 $0
Q4 2019

Feb 13, 2020
SELL
$220.06 - $304.07 $57,215 - $79,058
-260 Reduced 12.38%
1,840 $546,000
Q3 2019

Nov 13, 2019
BUY
$217.44 - $243.88 $2,174 - $2,438
10 Added 0.48%
2,100 $489,000
Q2 2019

Aug 09, 2019
BUY
$219.29 - $241.72 $458,316 - $505,194
2,090 New
2,090 $489,000

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Asahi Life Asset Management Co., Ltd. Portfolio

Follow Asahi Life Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asahi Life Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asahi Life Asset Management Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email